Deutsche Bank Aktiengesellschaft Cuts H. B. Fuller (NYSE:FUL) Price Target to $62.00

H. B. Fuller (NYSE:FUL – Get Free Report) had its price objective reduced by equities research analysts at Deutsche Bank Aktiengesellschaft from $72.00 to $62.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the specialty chemicals company’s stock. Deutsche Bank Aktiengesellschaft’s target price suggests a potential upside of 24.16% from the stock’s current price.

A number of other analysts also recently commented on the company. Zacks Research downgraded H. B. Fuller from a “strong-buy” rating to a “hold” rating in a research report on Friday, September 18th. Citigroup cut their price objective on H. B. Fuller from $75.00 to $63.00 and set a “buy” rating on the stock in a research report on Monday. Robert W. Baird reduced their price objective on H. B. Fuller from $75.00 to $65.00 and set an “outperform” rating for the company in a research note on Friday. Wall Street Zen lowered H. B. Fuller from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 25th. Finally, Weiss Ratings cut H. B. Fuller from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, September 14th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $64.62.

Check Out Our Latest Stock Analysis on FUL

H. B. Fuller Stock Up 1.1%

FUL stock traded up $0.56 during midday trading on Tuesday, reaching $49.94. 47,202 shares of the company’s stock traded hands, compared to its average volume of 666,612. The company has a quick ratio of 1.10, a current ratio of 1.82 and a debt-to-equity ratio of 0.95. The firm’s fifty day moving average price is $55.59 and its 200-day moving average price is $58.31. H. B. Fuller has a 52 week low of $46.70 and a 52 week high of $68.63. The company has a market cap of $2.69 billion, a price-to-earnings ratio of 13.89, a P/E/G ratio of 0.55 and a beta of 0.97.

H. B. Fuller (NYSE:FUL – Get Free Report) last posted its earnings results on Thursday, September 24th. The specialty chemicals company reported $1.52 earnings per share for the quarter, beating analysts’ consensus estimates of $1.47 by $0.05. H. B. Fuller had a return on equity of 12.65% and a net margin of 5.56%.The company had revenue of $938.17 million for the quarter, compared to analyst estimates of $945.59 million. During the same quarter last year, the company earned $1.26 earnings per share. The company’s revenue for the quarter was up 5.2% on a year-over-year basis. As a group, sell-side analysts forecast that H. B. Fuller will post 4.78 earnings per share for the current fiscal year.

Insider Activity at H. B. Fuller

In related news, VP Nathan Weaver sold 9,561 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $62.06, for a total value of $593,355.66. Following the sale, the vice president owned 11,739 shares in the company, valued at approximately $728,522.34. This trade represents a 44.89% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.83% of the stock is owned by company insiders.

Hedge Funds Weigh In On H. B. Fuller

Institutional investors have recently added to or reduced their stakes in the business. Hantz Financial Services Inc. raised its holdings in shares of H. B. Fuller by 432.9% in the 4th quarter. Hantz Financial Services Inc. now owns 778 shares of the specialty chemicals company’s stock valued at $46,000 after acquiring an additional 632 shares in the last quarter. Parallel Advisors LLC grew its holdings in shares of H. B. Fuller by 85.6% during the first quarter. Parallel Advisors LLC now owns 1,034 shares of the specialty chemicals company’s stock worth $64,000 after purchasing an additional 477 shares in the last quarter. Public Employees Retirement System of Ohio bought a new position in shares of H. B. Fuller in the second quarter worth approximately $86,000. Caitong International Asset Management Co. Ltd increased its position in shares of H. B. Fuller by 510.8% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,466 shares of the specialty chemicals company’s stock worth $87,000 after purchasing an additional 1,226 shares during the last quarter. Finally, Bayban purchased a new stake in H. B. Fuller in the fourth quarter valued at approximately $156,000. 95.93% of the stock is currently owned by institutional investors.

H. B. Fuller News Roundup

Here are the key news stories impacting H. B. Fuller this week:

  • Positive Sentiment: H.B. Fuller reported third-quarter adjusted EBITDA of approximately $187 million, while earnings per share of $1.52 exceeded the consensus estimate of $1.47. Management highlighted margin strength on the earnings call, supporting the company’s profitability outlook. H.B. Fuller Earnings Call Highlights Margin Strength
  • Positive Sentiment: JPMorgan maintained an “overweight” rating and Citi maintained a “buy” rating, with their revised price targets of $66 and $63, respectively, still implying substantial upside from recent trading levels. H.B. Fuller Analyst Price Target
  • Neutral Sentiment: R. Jeffrey Bailly, a former UFP Technologies chief executive, was elected to H.B. Fuller’s board as Ruth Kimmelshue resigned. The appointment adds industry and executive experience, but the board transition is not expected to immediately change operating results. H.B. Fuller Board Changes
  • Negative Sentiment: Third-quarter revenue of $938 million increased 5.2% year over year but fell short of analysts’ $946 million expectation. Investors may also be cautious following the company’s updated full-year outlook, particularly if it signals slower growth or continued pressure on demand. H.B. Fuller Q3 Results and Outlook
  • Negative Sentiment: Although both firms remain constructive, JPMorgan reduced its target from $67 to $66 and Citi cut its target sharply from $75 to $63. The downward revisions indicate analysts see less near-term upside despite the favorable ratings. Fuller Names Bailly to Board

About H. B. Fuller

(Get Free Report)

H.B. Fuller Company (NYSE: FUL) develops and manufactures specialty adhesives, sealants and other chemical-based products used in industrial and commercial applications. Its solutions help customers bond, seal, coat and assemble materials across a range of products and manufacturing processes.

The company serves markets including packaging, hygiene and disposable products, construction, transportation, electronics, durable assembly, woodworking, flooring, composites and renewable energy.

See Also

Analyst Recommendations for H. B. Fuller (NYSE:FUL)

Receive News & Ratings for H. B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.